Company: PTPI
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001811
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
1,000,000 and 0 shares authorized at June 30, 2025, and December 31, 2024, respectively, 0 and 0 shares issued and outstanding as of June 30, 2025, and December 31, 2024, respectively​​ —​​ —Common stock (par value $0.0001 per share, 7,000,000,000 and 250,000,000 shares authorized at June 30, 2025, and December 31, 2024, respectively; 42,284,502 and 421,124 shares issued and outstanding as of June 30, 2025, and December 31, 2024, respectively)​  4,228​ ​ 42​​​​​​​Additional paid-in capital​  114,478,202​ ​ 105,740,751Accumulated deficit​  (110,035,547)​ ​ (113,208,371)Total Stockholders’ Equity (Deficit)​  4,446,883​ ​ (7,467,578)​​​​​​​Total Liabilities and Stockholders’ Equity (Deficit)​$ 7,396,843​$ 10,635,310

​

The accompanying Notes are an integral part of the Unaudited Condensed Consolidated Financial Statements.

​